Prescribing patterns and medication costs in patients on maintenance haemodialysis and peritoneal dialysis.

ABSTRACT:

Background

Polypharmacy is a significant clinical issue for patients on dialysis but has been incompletely studied. We investigated the prevalence and costs of polypharmacy in a population-based cohort of participants treated with haemodialysis (HD) or peritoneal dialysis (PD).

Methods

We studied adults ≥20 years of age in Alberta, Canada receiving maintenance HD or PD as of 31 March 2019. We characterized participants as users of 0-29 drug categories of interest and those ≥65 years of age as users/non-users of potentially inappropriate medications (PIMs). We calculated the number of drug categories, daily pill burden, total annual cost and annual cost per participant and compared this to an age- and sex-matched cohort from the general Alberta population.

Results

Amon

SUBMITTER: Ghimire A 

PROVIDER: S-EPMC11852291 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature